under the microscope

Oral Alzheimer’s drug advances to Phase 2 trial.

“Asceneuron’s lead drug candidate ASN51 is a small molecule designed to block OGA, an enzyme that plays a role in protein aggregation. By preventing tau aggregation, the drug is intended to slow Alzheimer’s progression. In Phase 1 tests in healthy […]

under the microscope

A protein to restore memories lost to Alzheimer’s.

There’s a protein that’s found in the kidney and brain that’s cleverly called KIBRA. “Kauwe, Pareja-Navarro et al. identify a KIBRA-dependent mechanism to repair the plasticity at synapses that is dysregulated in neurons underlying the loss of memory in tauopathy.” […]